| Absorption | 
      | Blood-Brain Barrier | BBB+ | 0.9850 | 
      | Human Intestinal Absorption | HIA+ | 0.9908 | 
      | Caco-2 Permeability | Caco2+ | 0.7412 | 
      | P-glycoprotein Substrate | Substrate | 0.8125 | 
      | P-glycoprotein Inhibitor | Inhibitor | 0.8842 | 
                                                     | Inhibitor | 0.8078 | 
      | Renal Organic Cation Transporter | Inhibitor | 0.6956 | 
        
            | Distribution | 
        
      | Subcellular localization | Lysosome | 0.7989 | 
        
          | Metabolism | 
        
      | CYP450 2C9 Substrate | Non-substrate | 0.7980 | 
      | CYP450 2D6 Substrate | Substrate | 0.6737 | 
      | CYP450 3A4 Substrate | Non-substrate | 0.5092 | 
      | CYP450 1A2 Inhibitor | Inhibitor | 0.7057 | 
      | CYP450 2C9 Inhibitor | Non-inhibitor | 0.8935 | 
        | CYP450 2D6 Inhibitor | Inhibitor | 0.9137 | 
      | CYP450 2C19 Inhibitor | Inhibitor | 0.7763 | 
      | CYP450 3A4 Inhibitor | Non-inhibitor | 0.9289 | 
      | CYP Inhibitory Promiscuity | High CYP Inhibitory Promiscuity | 0.8902 | 
        
          | Excretion | 
        
        
          | Toxicity | 
        
      | Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8893 | 
                                                                    | Inhibitor | 0.8204 | 
      | AMES Toxicity | Non AMES toxic | 0.7839 | 
      | Carcinogens | Non-carcinogens | 0.8983 | 
      | Fish Toxicity | High FHMT | 0.9787 | 
      | Tetrahymena Pyriformis Toxicity | High TPT | 0.9934 | 
      | Honey Bee Toxicity | Low HBT | 0.8156 | 
      | Biodegradation | Not ready biodegradable | 1.0000 | 
      | Acute Oral Toxicity | III | 0.6920 | 
      | Carcinogenicity (Three-class) | Non-required | 0.7052 |